ASCO 2018 Roundtable - Lung Cancer - Potential Showdown of Two Positive Trials? Keynote 407 and IMPower 131

Article and Video CATEGORIES

Cancer Journey

ABOUT

Howard Jack West, MD, Founder, Board President

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

ASCO 2018 Roundtable - Lung Cancer - Potential Showdown of Two Positive Trials? Keynote 407 and IMPower 131

dbrock

Fri, 11/30/2018 - 15:30

Author

Howard (Jack) West, MD

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

In this roundtable video, the doctors discuss the potential showdown of two positive trials -- Keynote 407 - chemo combined with keytruda, and IMPower 131 - combination trial of carboplatin and abraxane alone or combined with tecentriq.

GRACE thanks the following sponsors for their support.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Next Previous link

Previous Post Next Post

Article

The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.

2025 Rare Cancers Patient Education Library

Video

In these videos, Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment. To watch the complete playlist, click here.

Small Cell Lung Cancer: Recognizing the Signs and Seeking Effective Treatment for this Aggressive Disease

Article

Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Head and Neck Cancer Awareness Month

Targeted Therapies Forum On Demand

Targeted Therapies in Lung Cancer March 15, 2025

How Did You Find Cancer Info Online

Targeted Therapies in Lung Cancer March 2025

Can SCLC also be treated with targeted therapy?

Targeted Therapies in Lung Cancer March 2025

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

Targeted Therapies in Lung Cancer March 2025

I was searching for this, Thank you so much for the info.

Article and Video CATEGORIES

Cancer Journey

Search By

GRACE thanks the following sponsors for their support.

Next Previous link

Related Content

Forum Discussions

Recent Comments